The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials

INTRODUCTION: Diabetic nephropathy is the leading cause of kidney failure. Clinical practice guidelines recommend prescribing renin–angiotensin aldosterone system inhibitors (RAASi) to prevent diabetic nephropathy at any stage. We conducted this systematic review and meta-analysis to compare the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsalemi, Noor, Sadowski, Cheryl A., Elftouh, Naoual, Louis, Maudeline, Kilpatrick, Kelley, Houle, Sherilyn K. D., Lafrance, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052620/
https://www.ncbi.nlm.nih.gov/pubmed/35484505
http://dx.doi.org/10.1186/s12882-022-02763-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052620/
https://www.ncbi.nlm.nih.gov/pubmed/35484505
http://dx.doi.org/10.1186/s12882-022-02763-1

Ejemplares similares